Promethazine for the treatment of agitation after electroconvulsive therapy: A case series

Journal of ECT

Volumn 21, Issue 2, 2005, Pages 118-121

  Vishne, Tali ^a,b   Amiaz, Revital ^a   Grunhaus, Leon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE   (Israel)

Author keywords

Agitation; ECT; Midazolam; Promethazine

Indexed keywords

ANTIHISTAMINIC AGENT; MIDAZOLAM; PROMETHAZINE;

ADULT; AGED; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CRYING; ELECTRIC SHOCK; FEAR; FEMALE; HUMAN; MALE; RESTLESSNESS;

ADULT; AGED; DRUG ADMINISTRATION SCHEDULE; ELECTROCONVULSIVE THERAPY; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PROMETHAZINE; PSYCHOMOTOR AGITATION; TREATMENT OUTCOME;

EID: 20444374119     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yct.0000166632.65932.a7     Document Type: Article

References (24)

1. Auriacombe M, Reneric JP, Usandizaga D, et al. Post-ECT agitation and plasma lactate concentrations. J ECT. 2000;16:263-267.
2. Augoustides JG, Greenblatt E, Abbas MA, et al. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review. J ECT. 2002;18:213-217.
3. Labbate LA, Miller JP. Midazolam for treatment of agitation after ECT. Am J Psychiatry. 1995;152:472-473.
4. Boylan LS, Haskett RF, Mulsant BH, et al. Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT. 2000;16:3-18.
5. Hickson GB, Altemeier WA, Clayton EW. Should promethazine in liquid form be available without prescription? Pediatrics. 1990;86:221-225.
6. Huf G, Coutinho ESF, Fagundes HM Jr, et al. Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study. BMC Psychiatry. 2002;2:4.
7. Alexander J, Tharyan P. Rapid tranquilization of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomized trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry. 2004;185:63-69.
8. Sadock BJ, Sadock VA. Pocket Handbook of Psychiatric Drug Treatment. Philadelphia, PA: Loppincott Williams & Wilkins; 2001.
9. Grunhaus L, Schreiber S, Dolberg OT, et al. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry. 2003;53:324-331.
10. Weil AJ. Exfoliative dermatitis after mediation with methylphenidate HC1. Ann Allergy. 1968;26:402.
11. Uhlig T, Huppe M, Brand K, et al. Zolpidem and promethazine in pre-anaesthetic medication. A pharmacopsychological approach. Neuropsychobiology. 2000;42:139-148.
12. Wright CD, Jilka J, Gentry WB. Efficacy of promethazine suppositories dispensed to outpatient surgical patients. Yale J Biol Med. 1998;71:391-395.
13. Fujii Y, Tanaka T, Harada C, et al. Epileptogenic activity induced by histamine H(1) antagonists in amygdala-kindled rats. Brain Res. 2003;991:258-261.
14. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging, 2nd ed. Washington, DC: American Psychiatric Press; 2000.
15. Devanand DP, Briscoe KM, Sackeim HA. Clinical features of postictal excitement. Convuls Ther. 1989;5:140-146.
16. Devanant DP, Sacheim HA. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement. Gen Hosp Psychiatry. 1992;14:345-349.
17. Hines AH, Labbate LA. Combination midazolam and droperidol for severe post ECT agitation. Convuls Ther. 1997;13:113-114.
18. Taylor G, Houston JB, Shaffer J, et al. Pharmacokinetics of promethazine and its sulphoxide metabolite after oral and intravenous administration to man. Br J Clin Pharmacol. 1983;15:287-293.
19. Digregorio GJ, Ruch E. Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine. J Pharm Sci. 1980;69:1457-1459.
20. Moolenar F. Absorption rate and bioavailability of promethazine from rectal and oral dosage forms. Int J Pharmaceutics. 1981;9:353-357.
21. Schwinghammer TL, Juhl RO, Dittert LW, et al. Comparison of the bioavailability of oral, rectal and intramuscular promethazine. Biopharmaceut Drug Disp. 1984;5:185-194.
22. Taylor G, Calvert RT, Houston JB. Determination of promethazine in body fluids. Anal Lett. 1979;12:1435-1442.
23. Koopowitz LF, Chur-Hansen A, Reid S, et al. The subjective experience of patients who received electroconvulsive therapy. Aust N Z J Psychiatry. 2003;37:49-54.
24. Battersby M, Ben-Tovim D, Eden J. Electroconvulsive therapy: a study of attitudes and attitude change after seeing an educational video. Aust N Z J Psychiatry. 1993;27:613-619.